Cargando…
Clinical staging of malignant pleural mesothelioma: current perspectives
Malignant pleural mesothelioma (MPM) is a disease with limited therapeutic options, the management of which is still controversial. Diagnosis is usually made by thoracoscopy, which allows multiple biopsies with histological subtyping and is indicated for staging purposes in surgical candidates. The...
Autores principales: | Bonomi, Maria, De Filippis, Costantino, Lopci, Egesta, Gianoncelli, Letizia, Rizzardi, Giovanna, Cerchiaro, Eleonora, Bortolotti, Luigi, Zanello, Alessandro, Ceresoli, Giovanni Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571821/ https://www.ncbi.nlm.nih.gov/pubmed/28860886 http://dx.doi.org/10.2147/LCTT.S102113 |
Ejemplares similares
-
Prognostic and predictive role of [(18)F]fluorodeoxyglucose positron emission tomography (FDG‐PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up‐front pemetrexed‐based chemotherapy
por: Zucali, Paolo Andrea, et al.
Publicado: (2017) -
P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment
por: Pezzuto, Federica, et al.
Publicado: (2021) -
Imaging in staging of malignant pleural mesothelioma
por: Truong, Mylene T, et al.
Publicado: (2004) -
Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009) -
Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma
por: Ceresoli, G L, et al.
Publicado: (2013)